Cell line · CVCL_3791
Papers63
5 more articles give this line's RRID in its Methods without naming the line nearby, so they are not listed.
1 to 20 of 63
Download this page as JSON| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| The VCPIP1-UBE3A Deubiquitination-Ubiquitination Cascade Contributes to Castration-Resistant Prostate Cancer Progression. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Castration-resistant prostate cancer cells are addicted to the high activity of cyclin-dependent kinase 2. | Mol Oncol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| SLPI is associated with AR-regulated epithelial adaptation and enzalutamide sensitivity in castration-resistant prostate cancer. | Front Pharmacol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| ERG Orchestrates a Dedifferentiation-Senescence-Inflammation Triad in Prostate Cancer. | Mol Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Spatial and single-cell transcriptomics reveal a HIF-1α/NF-κB-driven hypoxia-induced senescence axis in BPH epithelium. | Int J Biol Sci | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Impaired vitamin D signaling reveals neutrophils as key drivers of prostate cancer dissemination. | EMBO Mol Med | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Targeting FANCD2 to overcome enzalutamide resistance in prostate cancer. | Cancer Metab | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Dynamic Shifts in ER-Plasma Membrane Junctions Signaling Define Pro-Metastatic N-Glycosylation and Predict Prostate Cancer Progression. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| OGDHL Promotes Prostate Cancer Progression and Regulates Neuroendocrine Marker Expression and Nucleotide Abundance. | Mol Cancer Res | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A smart gene circuit for precise regulation of tumor cell behavior. | Synth Syst Biotechnol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Induction of ferroptosis in prostate cancer by CCDC719-13 via TRIM21-mediated ubiquitination of SLC7A11. | Cell Death Differ | 2026 | Its Methods give the RRID and name the line | PubMed | |
| CDC7 is a targetable regulator of advanced prostate cancer. | Sci Rep | 2025 | Its Methods give the RRID and name the line | PubMed | |
| A novel biochip-based liquid biopsy for extracellular vesicle RNA detection in prostate cancer. | Cancer Biol Ther | 2025 | Its Methods give the RRID and name the line | PubMed | |
| c-MYC mRNA destabilization inhibited lethal pancreatic cancer in vivo with significant survival outcomes. | Front Pharmacol | 2025 | Its Methods give the RRID and name the line | PubMed | |
| tRF-21LeuTAA Promotes Oxidative Stress by Altering Glutathione Metabolic Enzymes to Support Prostate Cancer Progression. | Cancer Res | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Tissue-dependent mechanosensing by cells derived from human tumors. | NPJ Biol Phys Mech | 2025 | Its Methods give the RRID and name the line | PubMed | |
| PSA Secretion from Single Circulating Tumor Cells of Metastatic Castration-Naïve Prostate Cancer Patients. | Cancer Res Commun | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Off-pore Nucleoporin sPOM121 Transcriptionally Propels β-Catenin-driven Tumor Progression and Immune Escape in Prostate Cancer. | Cancer Discov | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Ezetimibe Engineered L14-8 Suppresses Advanced Prostate Cancer by Activating PLK1/TP53-SAT1-Induced Ferroptosis. | Adv Sci (Weinh) | 2025 | Its Methods give the RRID and name the line | PubMed | |
| TRPM8 levels determine tumor vulnerability to channel agonists. | Mol Oncol | 2025 | Its Methods give the RRID and name the line | PubMed |
cell-lines-2026-11-14-0.1.0
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_3791/papers